<DOC>
	<DOCNO>NCT02087085</DOCNO>
	<brief_summary>This study ass safety efficacy brimonidine intravitreal implant patient geographic atrophy due age-related macular degeneration .</brief_summary>
	<brief_title>A Safety Efficacy Study Brimonidine Intravitreal Implant Geographic Atrophy Secondary Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Geographic atrophy due agerelated macular degeneration study eye Visual acuity well equal 20/125 study eye 20/200 fellow eye Cataract surgery LaserAssisted situ Keratomileusis ( LASIK ) study eye last 3 month Infections either eye last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>